Otrimed Clinical Research   Report issue

For profit Phase 3
Founded: Edgewood KY United States (2012)

Organization Overview

First Clinical Trial
2018
NCT03394911
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Otrimed Clinical Research

Active Ingredients

Drugs in Phase 3 Trials (1)

Paternal Facial Pheromone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Behavior, Addictive (Phase 3)

Disease (Phase 3)

Opioid-Related Disorders (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1